“Dual submission issues” retract both copies of ovarian cancer paper
Authors of a study on a potential biomarker for ovarian cancer have been hit with two retractions after the results were published twice. We don’t usually see both copies of a duplicated paper retracted, but this is a somewhat unusual case. In November 2011, a group of authors submitted the paper to Gynecologic Oncology. But two months’ prior, the … Continue reading “Dual submission issues” retract both copies of ovarian cancer paper